Gobburu Jogarao V S, Lawrence John
Division of Pharmaceutical Evaluation, Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evauation and Research, Food and Drug Administration, Rockville, Maryland 20852 USA.
Pharm Res. 2002 Jan;19(1):92-8. doi: 10.1023/a:1013615701857.
One of the main objectives of the nonlinear mixed effects modeling is to provide rational individualized dosing strategies by explaining the interindividual variability using intrinsic and/or extrinsic factors (covariates). The aim of the current study was to evaluate, using computer simulations and real data, methods for estimating the exact significance level for including or excluding a covariate during model building.
Original data were simulated using a simple one-compartment pharmacokinetic model with (full model) or without (null model) covariates (one or two). The covariate values in the original data were resampled (using either permutations or parametric bootstrap methods) to generate data under the null hypothesis that there is no covariate effect. The original and permuted data were fitted to null and full models, using first-order and first-order condition estimation (with or without interaction) methods in NONMEM, to compare the asymptotic and conditional p-value. Target log-likelihood ratio cutoffs for assessing covariate effects were derived.
The simulations showed that for sparse as well as dense data, the first-order condition estimation methods yielded the best results while the first-order method performs somewhat better for sparse data. Depending on the modeling objective, the appropriate asymptotic p-value can be substituted for the conditional significance level. Target log-likelihood ratio cutoffs should be determined separately for each covariate when exact p-values are important.
Resampling methods can be employed to estimate the exact significance level for including a covariate during nonlinear mixed effects model building. Some reasonable inferences can be drawn for potential application to design future population analyses.
非线性混合效应建模的主要目标之一是通过使用内在和/或外在因素(协变量)解释个体间变异性,从而提供合理的个体化给药策略。本研究的目的是使用计算机模拟和实际数据,评估在模型构建过程中用于估计纳入或排除协变量的确切显著性水平的方法。
使用具有(完整模型)或不具有(空模型)协变量(一个或两个)的简单单室药代动力学模型模拟原始数据。对原始数据中的协变量值进行重新采样(使用排列或参数自举法),以在不存在协变量效应的零假设下生成数据。使用NONMEM中的一阶和一阶条件估计(有或无交互作用)方法,将原始数据和置换后的数据拟合到空模型和完整模型,以比较渐近p值和条件p值。得出用于评估协变量效应的目标对数似然比临界值。
模拟表明,对于稀疏数据和密集数据,一阶条件估计方法产生的结果最佳,而一阶方法在稀疏数据上的表现略好。根据建模目标,适当的渐近p值可替代条件显著性水平。当确切的p值很重要时,应针对每个协变量分别确定目标对数似然比临界值。
在非线性混合效应模型构建过程中,可采用重新采样方法来估计纳入协变量的确切显著性水平。对于未来群体分析设计的潜在应用,可以得出一些合理的推论。